Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Novo Nordisk ... calorie diet and increased physical activity for weight management in obese adults, as well as heavily overweight people with a weight-related problem such as diabetes, high ...

You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a ...

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight off competition from rivals in a highly competitive market. The company announced the completion of two ...

Novo Nordisk A/S’s (NYSE:NVO) shared data Friday on its kidney outcomes trial, FLOW. The trial evaluated once-weekly injectable Ozempic for the treatment of type 2 diabetes. The FLOW (Evaluate ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy ... announced successful clinical trial results for its new oral diabetes medication, which also had significant weight loss effects as ...